|
|
|
|
|
searchin this issue
premium serviceseventsdirectory servicesadvertisingcustomer care |
Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Displaying 1 - 20 of 863 stories.
May 15, 2013
Cambrex (East Rutherford, NJ) says it has completed the previously announced expansion of the large-scale manufacturing facility at Charles City, IA. The major facility expansion was...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-completes-Charles-City-facility-expansion_52002.html May 14, 2013
Ampac Fine Chemicals swings to profit Ampac Fine Chemicals (AFC; Rancho Cordova, CA), a subsidiary of American Pacific (Las Vegas), recorded an operating profit of $3.8 million in its...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-14-May-2013_51978.html May 14, 2013
Active pharmaceutical ingredients (APIs) manufacturer ScinoPharm Taiwan (Shanhua, Taiwan) says that it has formed a strategic alliance with Coland Holdings (Shanghai) to develop a...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/ScinoPharm-and-Coland-form-alliance-for-oncological-injectable-products-for-China_51973.html May 14, 2013
Ampac Fine Chemicals (AFC; Rancho Cordova, CA), a subsidiary of American Pacific (Las Vegas), recorded an operating profit of $3.8 million in its fiscal second quarter, ended 31 March...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ampac-Fine-Chemicals-swings-to-profit_51971.html May 7, 2013
Teva’s API business reports fall in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel), recorded a 6.5% fall in...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-7-May_51808.html May 3, 2013
Cambrex (East Rutherford, NJ) reports a 58.6% increase in net profits for the first quarter, ended 31 March, compared with the year-ago period, to $11.16 million. First-quarter sales...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-reports-rise-in-profits-and-sales_51752.html May 3, 2013
Vertellus Specialties (Indianapolis) says that its facility at Antwerp has completed capital and other upgrades for the manufacture of niacin, or nicotinic acid, for pharmaceutical...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Vertellus-upgrades-Belgium-facility-for-API-niacin-manufacture_51741.html May 2, 2013
DSM's core net profit fell 13.4%, to €129 million ($170 million) during the first quarter of 2013, compared with the same period last year when it stood at €149 million, the...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/DSMs-net-profit-falls-13-percent-in-the-first-quarter-as-performance-materials-sales-decline_51661.html April 30, 2013
Lonza results in line with expectations Lonza, in its business update announcement for the first quarter of 2013, says that its business performance was solid and in line with...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-30-April_51592.html April 29, 2013
The active pharmaceutical ingredient (API) business of Covidien (Dublin) report an 11.4% rise in sales in the company’s second quarter, ended 29 March, compared with the year-ago...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Covidien-reports-rise-in-API-sales_51560.html April 29, 2013
Pharmaceutical company Ipsen (Paris) says that it expects a supply interruption for its product Increlex, a treatment for growth failure in children, as a result of the manufacturing...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ipsen-expects-Increlex-supply-interruption-due-to-issues-at-Lonza-Hopkinton-site_51556.html April 26, 2013
Chemical production in Argentina was up 2.6% during the first quarter of this year compared with the same quarter in 2012, according to figures released by state statistics office...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Argentinas-chemicals-output-up-2-6-percent-during-the-first-quarter_51529.html April 23, 2013
Vertellus Specialties (Indianapolis) has entered into a joint venture with Weifang Green Olive Chemical (Weifang, China) to expand significantly Vertellus's capacity to produce...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Vertellus-JV-to-produce-pyridine-and-picoline-in-China_51372.html April 23, 2013
Hikma to retain injectables business Hikma Pharmaceuticals (London) says it has concluded a review of the strategic options for its global Injectables business and decided that this...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-23-April_51368.html April 17, 2013
An explosion occurred at pharmaceutical company OlainFarm's (Olaine, Lativia) production site at 9.20 a.m. local time today, caused by a toluene vapor leak at the site's...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Explosion-at-site-in-Latvia-halts-production-at-two-lines_51228.html April 16, 2013
FDA’s self-identification process for 2014 begins in May The US FDA says that the generic drug facility self-identification reporting period for fiscal-year 2014 will begin on 1...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-16-April_51203.html April 15, 2013
Barentz Group (Hoofddorp, Netherlands) has acquired an undisclosed equity stake in NK Chemicals (NKC; Wakefield, UK) with the aim of strengthening the activities of each company in the...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Barentz-takes-stake-in-lanolin-distributor-NK-Chemicals_51172.html April 9, 2013
Teijin acquires 10% stake in Kyorin Holdings Teijin says it has acquired 7.59 million shares, or 10% of the outstanding shares of Kyorin Holdings (Tokyo), from Kyorin’s major...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-9-April_51019.html April 5, 2013
US FDA issued a warning letter late last month to the active pharmaceutical ingredient (API) manufacturing facility of Asada Milling Co. (Kanra, Japan), for deviating from cGMP. An FDA...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-issues-warning-letter-to-API-manufacturer-in-Japan_50968.html April 5, 2013
Active pharmaceutical ingredients (APIs) producer Hovione (Loures, Portugal) says it has entered into a copromotion and collaboration agreement with Ligand Pharmaceuticals (La...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Hovione-signs-agreement-with-Ligand-Pharmaceuticals-for-Captisol-technology_50967.html |
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|
Follow us on Twitter
